Fellowship · Houston, TX
Sponsored by University of Texas M D Anderson Cancer Center
Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer.
Cancer cell · 2021 · 489 citations · Huamin Wang
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.
Cancer cell · 2022 · 318 citations · Wai Foo
Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer.
Cancer cell · 2022 · 296 citations · Huamin Wang
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial.
The lancet. Gastroenterology & hepatology · 2022 · 241 citations · Asif Rashid
Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer.
Cancer discovery · 2022 · 259 citations · Huamin Wang
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 286 citations · Dipen Maru
Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer.
Cancer cell · 2022 · 230 citations · Huamin Wang
Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 173 citations · Wai Foo, Dipen Maru